Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
VI ›
VIA EXOSOMES
Trademark search for:
VIA EXOSOMES
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-06-03 — Application filed
2021-06-07 — Application filed
2021-08-26 — Application filed
2021-12-30 — Assigned to examiner
2021-12-31 — Final disposition recorded
2021-12-31 — Final disposition recorded
2021-12-31 — Final disposition recorded
2021-12-31 — Examiners amendment -written
2021-12-31 — Examiners amendment e-mailed
2021-12-31 — Notification of examiners amendment e-mailed
2021-12-31 — Examiner's amendment entered
2021-12-31 — Approved for pub - principal register
2022-01-04 — Assigned to lie
2022-01-04 — Law office publication review completed
2022-01-19 — Notification of notice of publication e-mailed
2022-02-08 — Published for opposition
2022-02-08 — Official gazette publication confirmation e-mailed
2022-04-05 — Noa e-mailed - sou required from applicant
2022-09-28 — Sou teas extension received
2022-09-28 — Sou extension 1 filed
2022-09-28 — Sou extension 1 granted
2022-09-30 — Notice of approval of extension request e-mailed
2023-03-29 — Sou teas extension received
2023-03-29 — Sou extension 2 filed
2023-03-29 — Sou extension 2 granted
2023-03-31 — Notice of approval of extension request e-mailed
2023-10-03 — Sou teas extension received
2023-10-03 — Sou extension 3 filed
2023-10-03 — Sou extension 3 granted
2023-10-05 — Notice of approval of extension request e-mailed
2024-04-04 — Sou teas extension received
2024-04-04 — Sou extension 4 filed
2024-04-04 — Sou extension 4 granted
2024-04-09 — Notice of approval of extension request e-mailed
2024-10-03 — Sou teas extension received
2024-10-03 — Notice of approval of extension request e-mailed
2024-10-03 — Sou extension 5 filed
2024-10-03 — Sou extension 5 granted
2025-10-14 — Application abandoned
2025-10-14 — Application abandoned
2025-10-14 — Final status recorded
Owner Information
Vivex Biologics Group, Inc.
Vivex Biologics Group, Inc.
Correspondent
Devonte King DAVID L. KING, SR., LLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
